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Lipid profile in a group of patients with Turner’s syndrome at
Clínica Universitaria Bolivariana in the Medellín city between 2000 and 2009*
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SUMMARY
Introduction: Turner syndrome patients can present lipid profile alterations, which associated with obesity, frequent in
these patients, causes increased cardiovascular risk, lowering their life expectancy. This research evaluates lipid profiles of
patients with Turner syndrome between 2000 and 2009 and these are associated to the karyotype and other risk factors for
coronary disease.
Objective: To describe the lipid profile and other cardiovascular risk factors in a group of girls with Turner syndrome.
Methods: This is a descriptive study, which evaluated the clinical records of 21 girls with Turner syndrome. We sought
metabolic risk factors for coronary disease such as lipid profile, weight, body mass index, and blood pressure.
Results: Age at time of diagnostics ranged between 8 months to 17 years, four patients were below 10 years of age and
17 patients were over 11 years of age. The karyotype revealed: 57.3% with 45x monosomy, 33% with 46xx-45x mosaicism,
and 9.5% with 46x-qx mosaicism. None of the patients was obese; the total cholesterol levels ranged from 116 mg/dl to 225
mg/dl with a mean of 168.7. When these patients were grouped by age, we found that 25% of those younger than 10 years
of age had high levels of cholesterol vs. 58.8% for those over 10 years of age. Regarding the karyotype of the six patients
with 46xx-45x karyotype, five (71.4%) presented hypercholesterolemia; 95.2% of the patients were normotensive.
Discussion: This research revealed Turner syndrome patients present lipid profile alterations at early ages.
Conclusion: It is important to include in the follow up protocol in these patients the lipid profile control and, thus, be able
to conduct early interventions to improve their quality of life.
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Perfil lipídico en un grupo de pacientes con síndrome de Turner en la Clínica Universitaria Bolivariana de la ciudad
de Medellín entre los años 2000-2009
RESUMEN
Introducción: Las pacientes con síndrome de Turner (ST) pueden presentar alteraciones en el perfil lipídico, lo que,
asociado con la obesidad, frecuente en estas pacientes,  produce un aumento del riesgo cardiovascular y reduce su esperanza
de vida. En este estudio se evalúan los niveles de perfil lipídico en pacientes con ST entre 2000-2009, y se asocia con el
cariotipo y otros factores de riesgo para enfermedad coronaria.
Objetivos: Describir el perfil lipídico en un grupo de niñas con ST y otros factores de riesgo cardiovascular.
Metodología: Estudio descriptivo  en el que  se evaluaron las historias clínicas de 21 niñas con ST. Se buscaron factores
de riesgo metabólico para enfermedad coronaria tales como perfil lipídico, peso, índice de masa corporal y cifras de presión
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arterial.
Resultados: En el momento del  diagnóstico la edad
osciló entre los 8 meses y 17 años; cuatro pacientes eran
menores de 10 años y 17 mayores de 11 años. El cariotipo
fue: 57.3% con monosomía 45x, 33%  mosaicismo 46xx-45x
y 9.5%  mosaicismo 46x-qx. Ninguna paciente presentó
obesidad; los niveles de colesterol total oscilaron entre 116
mg/dl-225 mg/dl con una media de 168.7. Al agrupar estas
pacientes por edad, se encontró  que 25% de las menores de
10 años tenían niveles altos de colesterol vs. 58.8%  de las
mayores de 10 años. En relación con el cariotipo de las 6
pacientes con cariotipo 46xx-45x, 5 (71.4%) presentaron
hipercolesterolemia; 95.2% eran normotensas.
Discusión: Este estudio demostró que las pacientes con
ST presentan alteración en su perfil lipídico desde edades
tempranas.
Conclusión: Es importante incluir en el  protocolo de
seguimiento de estas pacientes el control del perfil lipídico y
así poder realizar intervenciones tempranas y poder mejorar
su calidad de vida.
Palabras clave: Síndrome de Turner; Perfil lipídico;
Obesidad; Cariotipo;  Hipertensión arterial; Colesterol;
Triglicéridos.
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Turner syndrome (TS) is one of the most common
chromosomal anomalies, affecting approximately 3%
of fetuses and, of these, only 1% survives. It is
responsible for 7-10% of spontaneous abortions1; its
rate of occurrence is 1:2000 live births2. This pathology
is mainly caused by a monosomy of the X chromosome,
through partial or complete loss of the second X
chromosome or, in a lower percentage, through cell line
mosaicism1; this happens because of a failure in the
sexual chromatin separation during meiosis in the
gametocyte or during an early stage of embrionary
division.
Clinically, the syndrome characterized by low stature
(approximately 20 cm below average), micrognathia,
low hairline, high-arched palate, crowded teeth, short
webbed neck, shortened fourth metacarpal, cavitus
valgus, Madelung deformity, hyperconvex nails,
increased inter-mammary space (teletelia), scoliosis,
congenital hip dysplasia, osteoporosis, lymphedema,
gonadal failure, horseshoe kidney3, and cardiac
anomalies like: coarctation of the aorta, bicuspid aortic
valve, anomalous venous drainage, and mitral valve
prolapse4,5. In the long term, these patients may present
other types of complications like ischemic coronary
disease, where it has been found that these patients have
twice the risk compared to the normal population and
seven times greater risk of mortality, reducing their life
expectancy by 6 to 13 years5-8.
Patients with ST get medical care during childhood,
but most are released by the specialist when they reach
their final stature; thereby, disregarding early detection
of cardiovascular risk factors that lead to greater
morbidity and mortality risk. Due to the aforementioned,
long-term monitoring of these patient is necessary,
controlling cardiovascular risk factors like blood
pressure, lipid profile, glycemia, and early intervention;
said control may reduce morbidity and increase life
expectancy1.
To date, there are no studies in the city of Medellín
to justify this control. For this motive, these exams are
not routinely performed in these patients. The objective
of this study is to describe the behavior of the lipid
profile in a group of girls and female adolescents with
Turner syndrome in the Medellín.
METHOD
This descriptive study evaluated the clinical records
of 21 women with Turner Syndrome, who had attended
pediatric endocrinology consultation at the Clínica
Universitaria Bolivariana in the city of Medellín, Co-
lombia, during a period between the years 2000 to
2009; patients without karyotype were excluded. We
looked for metabolic risk factors in these women for
coronary disease like lipid profile, weight, body mass
index (BMI), and blood pressure readings (BP), in
addition to the use of estrogens. This study was approved
by the Clinic’s Research Committee and did not require
evaluation by the ethics committee, given that it was
considered a low-risk study. The statistical analysis
was conducted with the SPSS program.
RESULTS
We were able to identify 21 patients diagnosed for
TS who consult the Clínica Universitaria Bolivariana in
the city of Medellín; their ages at the time of diagnosis
ranged between 8 months and 17 years and, currently,
they are between 8 and 20 years of age; four patients
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were under 10 years of age (19.4%) and 17 patients
were older than 11 years of age (80.6%).
In all the patients assessed, their diagnosis was
corroborated with the karyotype; these were distributed
thus: 12 patients with 45x monosomy (57.3%), 7 patients
with 46xx-45x mosaicism (33%), and 2 patients with
46x-qx mosaicism (9.5%).
Regarding anthropometric measurements, it was
noted that 10 patients (47.6%) were slim, i.e., they were
within the 3rd to 49th percentile of the body mass index
(BMI), 9 patients (42.8%) had a BMI between the 50th
and 84th percentiles, and two patients (9.5%) were
overweight with BMI in the 85th percentile; none of the
patients was obese.
With respect to lipid profile, we found measurements
for 100% (21) of the patients (Table 1); total cholesterol
levels ranged from 116 mg/dl to 225 mg/dl with a mean
of 168.7 (+25.8 mg/dl); 47.6% (10 patients) had levels
considered high for their age (>170 mg/dl) and 52.3%
(11 patients) had lower values (Graphic 1). Upon
grouping these patients by age, we found that 25% of
the patients younger than 10 years of age had high
cholesterol levels vs. 58.8% (10 patients) of the patients
who were older than 10 years of age. Triglyceride levels
ranged between 44 mg/dl and 227 mg/dl with a mean of
99.85 mg/dl (+46.12 mg/dl); in three patients (14.2%),
all older than 10 years of age, we found high triglyceride
levels (>150 mg/dl). Values for HDL and LDL ranged
between 26 mg/dl and 87.7 mg/dl and 41 mg/dl and 140
mg/dl, respectively. The means were 47.06 mg/dl for
HDL and 140 mg/dl for LDL. Results for HDL were
distributed in the following manner: two patients
(11.7%) had HDL levels below 40 mg/dl (26 and 34 mg/
Table 1
Patients evaluated with anthropometric indicators and lipid profile
Anthropometric data and lipid profile
Patient     Age      Weight     Height     BMI       %BMI        Total    Triglycerides    LDL     HDL        Hypo-             Controlled
                                                                                          cholesterol   thyroidism    hypothyroidism
1 8 22.5 1.216 15.3 15 189 99 135 34 No NA
2 8 18.0 1.11 14.5 15 162 44 80 73 No NA
3 9 32.0 1.3 18.9 85 168 110 100 46 No NA
4 10 26.0 1.219 17.49 50 157 97 82 55 No NA
5 11 32.0 1.428 15.69 3 138 72 74 50 No NA
6 11 27.0 1.231 17.81 50 116 137 41 46.8 YES YES
7 11 36.0 1.373 19.09 50 149 74 88 45.6 No NA
8 12 37.0 1.34 20.6 85 174 70 100 60 No NA
9 12 35.1 1.293 21.0 50 150 152 63 56 YES YES
10 13 35.0 1.397 17.93 15 185 61 113 60 No NA
11 13 41.9 1.43 20.48 50 198 55 140 47 YES YES
12 14 30.0 1.369 16.0 3 180 119 78 62 No NA
13 14 43.5 1.459 20.4 50 193 227 93 54 No NA
14 14 28.5 1.38 14.92 3 180 119 78 62 No NA
15 15 32.0 1.393 16.49 3 150 64 83 54 No NA
16 15 35.0 1.39 18.08 15 153 70 91 48 No NA
17 16 50.5 1.51 22.08 50 192 58 138 42 YES YES
18 16 52,5 1.523 22.63 50 142 68 85 44 No NA
19 16 43.0 1.52 18.61 15 128 107 81 26 No NA
20 18 40.0 1.402 20.34 25 178 169 104 40 No NA
21 20 61.5 1.61 23.72 50 225 125 123 87.7 No NA
NA: Not applicabl
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dl), 13 patients (61.9%) had
values between 40 and 60 mg/dl,
and six patients (28.5%) had
values above 60 mg/dl. Again,
when grouped by age, no diffe-
rence was found relating to HDL
(52 mg/dl); in turn, when asso-
ciating age to LDL levels we
found four patients (19%) older
than 10 years of age presenting
levels above 110 mg/dl (113, 140,
138, and 123.7 mg/dl), vs. one
patient (4.7%) younger than 10
years of age at 135 mg/dl.
Another parameter evaluated was
the presence or non-presence of
hypothyroidism, finding that four
(19%) of the 21 patients pre-
sented this associated pathology;
the four patients were adequately
controlled.
When relating total choles-
terol levels to karyotype, we
found: for the 45x karyotype,
girls as young as 11 years of age9 and not influenced by
the type of karyotype. Of the 21 patients described in
this study, only one patient reported high tension values
(above the 99th percentile for their age and stature).
Upon evaluating the lipid profile, we found high
total cholesterol levels in 10 patients, corresponding to
47.6% (two more patients had cholesterol limit values,
168 and 168.4 mg/dl, respectively), which was more
frequent in the group over 10 years of age; 14.2% (3
patients) presented hypertriglyceridemia; 9.5% (2
patients) had HDL below 40 mg/dl and another 23.8%
(5 patients) had LDL levels above 110 mg/dl. These
data are similar to that described by Garden et al.4, who
suggested that hypercholesterolemia occurs in 50% of
the women with TS (32 patients evaluated) over 21
years of age, but unlike the study by Garden et al.4, all
our patients are younger than 21 years of age and the
youngest patient affected in our group is eight years old,
suggesting that lipid alteration begins during childhood.
It is worth mentioning the finding of a relationship
between the 46xx-45x mosaicism and high levels of
total cholesterol (57.5% of the patients), which was not
found with the other mutations, and does not agree with
58% (7 patients) had levels below 170 mg/dl and 42%
(5 patients) had greater levels. Of the six patients with
46xx-45x karyotype, 5 (71.4%) had hypercholes-
terolemia, two (28.4%)  had values lower than those
described. Finally, for the 46xx-qx mosaicism none of
the two patients had high total cholesterol levels (Graphic
2).
Another risk factor evaluated for cardiovascular
disease was blood pressure levels (BP); only one patient
(4.7%) reported values above the 99th percentile
according to stature and age (according to stature graphic
for patients diagnosed with TS); 20 patients (95.2%)
had readings within the 25th and 90th percentiles (Table
2).
DISCUSSION
Turner syndrome patients are exposed to different
risk factors for coronary disease, like arterial hyper-
tension, generally of early onset, and with a three times
greater risk than the normal population of women;
resistance to insulin, which affects 10-34% of the
women with TS8 and hypercholesterolemia, shown in
Graphic 2. Relationship between karyotype and
total cholesterol levels
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Graphic 1. Total cholesterol levels with relation to age
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that previously reported in literature10 (Graphic 2).
Significant data that could serve as screening to carry
out lipid profile in patients with TS with this alteration
and which makes us think of the possible protective
effect or of intrinsic risk according to the type of
chromosomal alteration.
Also, obesity is common in women with TS and it is
associated to high triglyceride and cholesterol levels,
which contributes to increased cardiovascular risk11.
These patients present central-type obesity with
increased waist/hip index and reduced body mass free
of fat12. However, in our study we found no patients
with obesity; on the contrary, most of the patients
described (90.4%) had a BMI between the 3rd and 85th
percentiles; likewise, we could not correlate high lipid
profile levels with the higher BMIs. These results could
be explained by early intervention of risk factors done
in endocrinology consultation, which emphasizes a
balanced diet and regular physical activity from the first
consultation. But this must take into account the lipolytic
effect of the growth hormone, used by 100% of the
patients evaluated.
In our study we found no significant alteration of
blood pressure levels7, contrary to most studies published
on patients with TS. This leads us to think of the
possible association between blood pressure levels and
BMI in TS patients. But, independent of our finding,
there is a clear need to assess blood pressure levels in
patients with TS.
In the past, the increased prevalence of coronary
disease in women with TS was considered a consequence
of premature ovarian failure that caused a loss of the
Table 2
 Blood pressure measurements and percentiles with relation to height and age
Blood pressure levels according to height and age
Patient Age Height percentile*            Systolic BP           Diastolic BP             BP percentile
1 8 95 80 55           <p 50
2 8 50 90 50          <p 50
3 9 >p 97 95 60          <p 50
4 10 50 88 55          <p 50
5 11 p 50 85 60         <p 50
6 11 p97 130 80         >p 99
7 11 97 90 60         <p 50
8 12 90 105 62        <p 50
9 12 70 80 55       <p 50
10 13 90 90 60       <p 50
11 13 97 90 60       <p 50
12 14 95 90 60       <p 50
13 14 75 110 80       <p 50
14 14 75 100 70      <p 50
15 15 75 100 60      <p 50
16 15 75 110 70      50-75
17 16 95 90 60      <p 50
18 16 95 100 60      <p 50
19 16 95 100 70      <p 50
20 18 25-50 100 70      <p 50
21 20 >p 97 110 70      <p 50
*  Height percentiles measured according to graphic for patients diagnosed with Turner syndrome
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estrogen effect and increased adiposity; we found a
relationship between high levels of total cholesterol and
triglycerides with increased age, not evidenced with
HDL and LDL levels. Our finding is interesting in that
the lipid alteration predominates according to the age
group, given that 90% of the patients with high levels of
total cholesterol and 100% of the patients with high
levels of triglycerides were over 12 years of age. These
data could be useful when establishing an adequate age
to conduct lipid screening in girls and adolescent females
with TS. This association could also be explained by the
arrival of puberty and the estrogen deficit presented by
these patients. But, currently, the theory of the protective
effect of the ovarian hormones in cardiac disease has
lost strength14. In a study carried out by Cooley et al.9,
patients with TS were compared with patients with
46xx karyotype with ovarian failure who did not receive
estrogen treatment. They found that patients with Turner
syndrome had higher levels of LDL cholesterol, total
cholesterol, and triglycerides tan the control group,
suggesting that it may be caused by haploinsufficiency
of an unknown gene in the X chromosome that is not
inactivated (this gene may contribute to the favorable
lipid profile women have in comparison to men, with
the second X chromosome somehow being cardio-
protective)1. This hypothesis has gained support in
recent years given that a great number of X chromosome
genes escape inactivation, suggesting that healthy women
experience a different effect linked to the X compared,
both to men and to patients diagnosed with TS, which
are monosomic for the X6 chromosome. In this study, it
is worth stating that patients using estrogen replacement
(12 patients), eight of them had hypercholesterolemia
and two had hypertriglyceridemia, which would be
against the protective effect of the estrogens.
Additionally, although four of the 21 patients were
being treated with levothyroxine due to hypothyroidism
diagnosis; all were suitably controlled given that this
diagnosis does not affect cholesterol and triglyceride
levels. All the aforementioned would justify similar
studies in different regions of the country to establish if
nutritional factors could be associated to possible lipid
profile alterations in patients with TS.
In this study, the assessment of the lipid profile was
done without bearing in mind growth hormone
treatment13,14 (duration, age of onset, dosage), which
has clear lipolytic and hypolipemiant effects that could
interfere with the results. This could justify performing
a lipid profile after removing the growth hormone.
CONCLUSION
In this study, we described the lipid and anthro-
pometric profiles of a group of girls and adolescent
females with TS who attended pediatric endocrinology
consultation at Clínica Universitaria Bolivariana; a
total of 21 patients were evaluated ranging from 8 to 20
years of age. Upon conducting the analysis, we found
that their BMI was not above the normal values; however,
this may be explained because they were under endocrine
care, which has early intervention to control risk factors
(diet, regular physical activity). We also confirmed that
the patients with TS do reveal lipid profile alteration
from early ages even with estrogen replacement and
growth hormone treatment; although these data are
only descriptive and the population group is small.
Further comparative studies would be rendered with
girls without the disease to determine why these patients
are exposed to greater risk of dyslipidemia and,
consequently, to coronary disease, and to also establish
if the karyotype is an independent risk factor for said
complications. As a final conclusion, when evaluating
patients with TS bear in mind that they need monitoring
of cardiovascular risk factors throughout their lives.
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